Author

Elizabeth Peters

VLP Therapeutics (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Amber L. MoreyiD· 1 shared Andrés A. Quiñones-MolinaiD· 1 shared Hisashi AkiyamaiD· 1 shared Jonathan SmithiD· 1 shared Josiane FofanaiD· 1 shared Kenta MatsudaiD· 1 shared Luis Romero· 1 shared Mai KomoriiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Amber L. MoreyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintNov 1, 2023

Incorporation of 5 methylcytidine alleviates innate immune response to self-amplifying RNA vaccine

Mai Komori, Amber L. Morey, Andrés A. Quiñones-Molina…·Hisashi Akiyama

This study shows that incorporating 5-methylcytidine into saRNA vaccines reduces innate immune activation and adverse effects while maintaining strong immune responses.

21 citations

mousebulk RNA-seq

𝕏 PostBluesky